CorVel Corporation (CRVL) AI Stock Analysis

NASDAQ: CRVLAI research summary: business, growth, valuation, analysts, bull and bear case.

CRVL AI stock analysis summary

AI Research

CorVel Corporation provides healthcare cost containment and patient management services across workers' compensation, auto, and liability claims. Over the trailing twelve months, the company generated $983.7M in revenue with a profit margin of 11.7%. CorVel produced $110.3M in free cash flow in FY2026 and held $227.5M in net cash as of June 30, 2026.

Market cap
$4.03B
Revenue (TTM)
$983.7M
P/E
35.6x
fwd 23.8x
1Y return
12.9%
S&P 500 16.8%
Avg. target
$0.00

Bull case

  • CorVel increased annual free cash flow from $37.4M in FY2022 to $110.3M in FY2026.
  • The balance sheet maintains low leverage with $227.5M in net cash and a debt-to-equity ratio of 0.07 as of June 30, 2026.
  • Quarterly earnings grew 21.2% year-over-year in the period ended June 30, 2026, alongside a 10.7% increase in quarterly revenue.

Bear case

  • CorVel trades at a trailing P/E of 35.6x and an EV-to-EBITDA of 19.0x, above the US-listed Financial Services peer medians of 12.1x and 11.7x.
  • Annual revenue growth slowed to 7.0% in FY2026 compared to 12.6% in FY2025 and 16.9% in FY2022.
  • CorVel's 5-year return of 36.9% lagged the S&P 500 return of 83.0% over the same period.

What CorVel does

CorVel Corporation, headquartered in Fort Worth, Texas, provides comprehensive solutions in workers' compensation, auto, liability, and health services across the United States. Founded in 1987, it assists employers, third party administrators, insurance companies, and government agencies in managing medical costs and healthcare claims. The company leverages artificial intelligence, machine learning, and natural language processing to optimize episode-of-care management. Core network solutions include medical fee auditing, preferred provider management, reimbursement services, utilization review, pharmacy services, and directed care. CorVel also delivers patient management services such as claims management, case management, 24/7 nurse triage, and vocational rehabilitation.

Growth and profitability

CorVel expanded annual revenue from $646.2M in FY2022 to $718.6M in FY2023, $795.3M in FY2024, $895.6M in FY2025, and $958.5M in FY2026, representing a 5-year revenue CAGR of 11.6%. Net income grew from $66.4M in FY2022 to $110.3M in FY2026, while net margin rose from 10.3% to 11.5%. Operating margin improved from 13.1% in FY2022 to 14.9% in FY2026, and gross margin reached 24.3%. In the latest quarter ended June 30, 2026, quarterly revenue increased 10.7% year-over-year, and quarterly earnings grew 21.2%. Trailing twelve month revenue reached $983.7M with an operating margin of 16.7% and EPS of $2.24.

CRVL income statement →

Balance sheet and cash flow

As of June 30, 2026, CorVel held $255.9M in cash and short-term investments against $28.4M in total debt, resulting in a net cash position of $227.5M. Total assets reached $689.7M compared to $408.9M in shareholders' equity, with a current ratio of 1.94 and a debt-to-equity ratio of 0.07. In FY2026, operating cash flow was $155.6M, which funded $45.4M in capital expenditures to generate $110.3M in free cash flow. CorVel allocated $56.2M toward share buybacks during FY2026.

CRVL balance sheet →

Valuation and performance

CorVel trades at a trailing P/E of 35.6x and a forward P/E of 23.8x, compared to medians of 12.1x and 10.8x for its US-listed Financial Services peers. Its price-to-sales ratio stands at 4.1x versus the peer median of 3.2x, while EV-to-EBITDA is 19.0x against the peer median of 11.7x. The company has a market capitalization of $4.03B and an enterprise value of $3.47B. CorVel shares gained 12.9% over the past year and 36.9% over the past 5 years, trailing the S&P 500 returns of 16.8% and 83.0% over the same timeframes.

CRVL key metrics →

What analysts expect

Wall Street coverage reflects a mean price target of $0.00 against CorVel's last close of $79.69 on October 16, 2026. The company is scheduled to report its next earnings on November 3, 2026. Inside ownership represents 38.9% of shares, institutional holdings account for 56.1%, and short interest stands at 10.6% of the float.

Key risks and what to watch

  • CorVel's trailing twelve month operating margin of 16.7% is below the US-listed Financial Services peer median of 37.7%.
  • Short interest represents 10.6% of the float as of October 16, 2026.
  • The stock trades 28.9% above its 200-day moving average and near its 52-week high of $83.37.

AI-generated research summary. Written with AI from Quotelinks data as of October 16, 2026 and checked so every figure matches that data. For information only, not investment advice. Disclaimer

About this CRVL AI stock analysis

This page is an AI-written research summary of CorVel Corporation (CRVL). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: CRVL income statement, CRVL balance sheet, CRVL key metrics, CRVL chart. See the CRVL stock overview for the latest quote and news.

CRVL AI stock analysis FAQ

What does CorVel Corporation do?

CorVel Corporation provides healthcare cost containment and patient management services across workers' compensation, auto, liability, and health programs. The company uses artificial intelligence and machine learning tools to deliver network solutions, medical fee auditing, and claims management.

Does CorVel pay a dividend?

CorVel does not report dividend payments. The company allocated its cash flow toward $45.4M in capital expenditures and $56.2M in share buybacks during FY2026.

How strong is CorVel's balance sheet?

As of June 30, 2026, CorVel held $255.9M in cash and short-term investments and $28.4M in total debt, resulting in $227.5M in net cash. Its current ratio stood at 1.94 with a debt-to-equity ratio of 0.07.

When does CorVel report earnings next?

CorVel is scheduled to report its next earnings on November 3, 2026.

How has CorVel performed relative to the S&P 500?

Over the 1-year period leading to October 16, 2026, CorVel returned 12.9% compared to 16.8% for the S&P 500. Over 5 years, CorVel returned 36.9% versus 83.0% for the S&P 500.

More Financial Services AI stock analysis